Inducible nitric oxide contributes to viral pathogenesis following highly pathogenic influenza virus infection in

Lucy A Perrone1, Jessica A Belser, Debra A Wadford

  • 1Immunology and Pathogenesis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.

Insights

Nitric oxide (NO) exacerbates severe outcomes in highly pathogenic influenza virus infections. Inhibiting NO production in mice reduced disease severity and mortality from H5N1 and 1918 influenza viruses.

Area of Science:

  • Immunology
  • Virology
  • Pathology

Background:

  • Highly pathogenic influenza A viruses (HPAIVs), such as avian H5N1 and the 1918 pandemic strain, cause severe respiratory disease.
  • Influenza infection leads to pulmonary congestion and inflammation, involving reactive oxygen species and immune cells.
  • Nitric oxide (NO) is a key signaling molecule in inflammatory responses, but its role in HPAIV pathogenesis is not fully understood.

Purpose of the Study:

  • To investigate the role of nitric oxide (NO) in the pathogenesis of highly pathogenic influenza virus infections in a mouse model.
  • To determine if NO levels are elevated during H5N1 and 1918 influenza virus infections.
  • To assess the impact of NO inhibition on disease severity and mortality.

Main Methods:

  • Mice were infected with H5N1, 1918, or seasonal H1N1 influenza viruses.
  • Nitric oxide (NO) levels were measured in infected mice.
  • Inducible NO synthase knockout (NOS2(-/-)) mice and wild-type littermates were challenged with HPAIVs.
  • Mice infected with the 1918 virus were treated with a nitric oxide synthase (NOS) inhibitor.

Main Results:

  • Mice infected with H5N1 and 1918 viruses showed higher NO levels compared to those infected with seasonal H1N1.
  • NOS2(-/-) mice exhibited reduced morbidity, mortality, and lung cytokine production after H5N1 and 1918 virus challenge.
  • Treatment with a NOS inhibitor delayed weight loss and mortality in mice infected with the 1918 virus.

Conclusions:

  • Nitric oxide (NO) plays a significant role in the pathogenesis of H5N1 and 1918 influenza virus infections.
  • Inhibition of NO production or signaling can ameliorate disease severity and reduce mortality in HPAIV infections.
  • Targeting NO pathways may represent a therapeutic strategy for severe influenza.

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...